KPTI logo

Karyopharm Therapeutics (KPTI) CAPEX

Annual CAPEX

$142.00 K
NaN%

December 31, 2024

Summary

Performance

1-Year Change

-

3-Year Change

-97.51%

5-Year Change

-31.07%

15-Year Change

+129.03%

KPTI CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

14.76%
KPTI annual capital expenditures is higher than 14.76% of companies in Healthcare sector

High & Low

All-time High

$5.71 M
KPTI annual capital expenditures is currently -97.51% below its historical high of $5.71 million

3-Year Low

$118.00 K
KPTI annual capital expenditures is currently +20.34% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KPTI previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
KPTI next annual earnings announcement has not yet been scheduled

OtherKPTIcash flowmetrics:

Annual FCF

-$127.63 M
KPTI annual free cash flow is -$127.63 million

Annual CFO

-$127.49 M
KPTI annual cash flow from operations is -$127.49 million

Annual CFI

$95.47 M
KPTI annual cash flow from investing activities is $95.47 million

Annual CFF

$41.65 M
KPTI annual cash flow from financing activities is $41.65 million

Quarterly CAPEX

-$53.00 K
-$53.00 K-100.00%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

KPTI Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.51%
KPTI quarterly capital expenditures is higher than 2.51% of companies in Healthcare sector

High & Low

All-time High

$6.00 M
KPTI quarterly capital expenditures is currently -100.88% below its historical high of $6.00 million

3-Year Low

-$293.00 K

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KPTI previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
KPTI next earnings announcement is scheduled for May 8, 2025

OtherKPTIcash flowmetrics:

Quarterly FCF

-$25.76 M
KPTI quarterly free cash flow is -$25.76 million

Quarterly CFO

-$25.81 M
KPTI quarterly cash flow from operations is -$25.81 million

Quarterly CFI

$14.80 M
KPTI quarterly cash flow from investing activities is $14.80 million

Quarterly CFF

$680.00 K
KPTI quarterly cash flow from financing activities is $680.00 thousand

TTM CAPEX

$142.00 K
-$53.00 K-27.18%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

KPTI TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.57%
KPTI TTM capital expenditures is higher than 13.57% of companies in Healthcare sector

High & Low

All-time High

$6.12 M
KPTI TTM capital expenditures is currently -97.68% below its historical high of $6.12 million

3-Year Low

-$175.00 K

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KPTI previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
KPTI next earnings announcement is scheduled for May 8, 2025

OtherKPTIcash flowmetrics:

TTM FCF

-$127.63 M
KPTI TTM free cash flow is -$127.63 million

TTM CFO

-$127.49 M
KPTI TTM cash flow from operations is -$127.49 million

TTM CFI

$95.47 M
KPTI TTM cash flow from investing activities is $95.47 million

TTM CFF

$41.65 M
KPTI TTM cash flow from financing activities is $41.65 million

KPTI CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.0%0.0%
3 y3 years-97.5%0.0%0.0%
5 y5 years-31.1%0.0%0.0%

KPTI CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.5%+20.3%-127.2%+81.9%-97.5%+181.1%
5 y5-year-97.5%+20.3%-100.9%+81.9%-97.7%+181.1%
alltimeall time-97.5%+149.1%-100.9%+81.9%-97.7%+181.1%

Karyopharm Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
$142.00 K(+20.3%)
-$53.00 K(<-9900.0%)
$142.00 K(-27.2%)
Sep 2024
-
$0.00(0.0%)
$195.00 K(0.0%)
Jun 2024
-
$0.00(-100.0%)
$195.00 K(0.0%)
Mar 2024
-
$195.00 K(>+9900.0%)
$195.00 K(+65.3%)
Dec 2022
$118.00 K(-97.9%)
$0.00(-100.0%)
$118.00 K(-167.4%)
Sep 2022
-
$39.00 K(>+9900.0%)
-$175.00 K(-103.0%)
Jun 2022
-
$0.00(-100.0%)
$5.79 M(0.0%)
Mar 2022
-
$79.00 K(-127.0%)
$5.79 M(+1.4%)
Dec 2021
$5.71 M(+3839.3%)
-$293.00 K(-104.9%)
$5.71 M(-6.7%)
Sep 2021
-
$6.00 M(+4946.2%)
$6.12 M(+4123.4%)
Dec 2020
$145.00 K(-29.6%)
$119.00 K(>+9900.0%)
$145.00 K(+90.8%)
Sep 2020
-
$0.00(-100.0%)
$76.00 K(-58.5%)
Jun 2020
-
$16.00 K(+60.0%)
$183.00 K(+9.6%)
Mar 2020
-
$10.00 K(-80.0%)
$167.00 K(-18.9%)
Dec 2019
$206.00 K(-91.3%)
$50.00 K(-53.3%)
$206.00 K(-83.5%)
Sep 2019
-
$107.00 K(>+9900.0%)
$1.25 M(-23.5%)
Jun 2019
-
$0.00(-100.0%)
$1.63 M(-19.6%)
Mar 2019
-
$49.00 K(-95.5%)
$2.03 M(-14.1%)
Dec 2018
$2.36 M
$1.09 M(+122.6%)
$2.36 M(+78.3%)
Sep 2018
-
$491.00 K(+23.7%)
$1.32 M(+57.6%)
DateAnnualQuarterlyTTM
Jun 2018
-
$397.00 K(+3.9%)
$841.00 K(+89.4%)
Mar 2018
-
$382.00 K(+594.5%)
$444.00 K(+616.1%)
Dec 2017
$62.00 K(-11.4%)
$55.00 K(+685.7%)
$62.00 K(+93.8%)
Sep 2017
-
$7000.00(-72.0%)
$32.00 K(-54.3%)
Dec 2016
$70.00 K(-95.1%)
$25.00 K(>+9900.0%)
$70.00 K(-87.3%)
Sep 2016
-
$0.00(-100.0%)
$550.00 K(-19.9%)
Jun 2016
-
$6000.00(-84.6%)
$687.00 K(-46.2%)
Mar 2016
-
$39.00 K(-92.3%)
$1.28 M(-9.8%)
Dec 2015
$1.42 M(-50.0%)
$505.00 K(+268.6%)
$1.42 M(+40.2%)
Sep 2015
-
$137.00 K(-77.0%)
$1.01 M(-68.0%)
Jun 2015
-
$596.00 K(+234.8%)
$3.16 M(+9.4%)
Mar 2015
-
$178.00 K(+79.8%)
$2.89 M(+1.9%)
Dec 2014
$2.83 M(+4871.9%)
$99.00 K(-95.7%)
$2.83 M(+2.4%)
Sep 2014
-
$2.29 M(+605.6%)
$2.77 M(+446.8%)
Jun 2014
-
$324.00 K(+159.2%)
$506.00 K(+178.0%)
Mar 2014
-
$125.00 K(+290.6%)
$182.00 K(+219.3%)
Dec 2013
$57.00 K(-52.9%)
$32.00 K(+28.0%)
$57.00 K(+128.0%)
Sep 2013
-
$25.00 K
$25.00 K
Dec 2012
$121.00 K(-67.8%)
-
-
Dec 2011
$376.00 K
-
-

FAQ

  • What is Karyopharm Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics quarterly CAPEX year-on-year change?
  • What is Karyopharm Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics TTM CAPEX year-on-year change?

What is Karyopharm Therapeutics annual capital expenditures?

The current annual CAPEX of KPTI is $142.00 K

What is the all time high annual CAPEX for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high annual capital expenditures is $5.71 M

What is Karyopharm Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of KPTI is -$53.00 K

What is the all time high quarterly CAPEX for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high quarterly capital expenditures is $6.00 M

What is Karyopharm Therapeutics quarterly CAPEX year-on-year change?

Over the past year, KPTI quarterly capital expenditures has changed by $0.00 (0.00%)

What is Karyopharm Therapeutics TTM capital expenditures?

The current TTM CAPEX of KPTI is $142.00 K

What is the all time high TTM CAPEX for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high TTM capital expenditures is $6.12 M

What is Karyopharm Therapeutics TTM CAPEX year-on-year change?

Over the past year, KPTI TTM capital expenditures has changed by $0.00 (0.00%)